Lab21 appoints group director
Of quality, regulatory affairs and operations excellence
Dr Logue worked for almost two decades in divisions of Abbott Laboratories. He was most recently division vice president World Wide Manufacturing for Abbott Diabetes Care, moving from division vice president European Operations. Prior to this he was operations director for Abbott Diagnostics Division Ireland, and director of Quality & Regulatory and marketing manager for Abbott Diagnostics Division in Germany.
Dr Logue said: ‘Lab21 has achieved remarkable progress within the past 4 years, growing five times in size. I am looking forward to contributing to its future success.’
You may also like
Manufacturing
Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference
By taking a three-tiered approach to protecting patients and personnel and ensuring plant compliance, GEA adopts a consultative approach to helping its customers navigate the responsibilities of pharmaceutical manufacturing safety with confidence
Analysis
From ozone protection to climate action: the global transition away from CFCs and HFAs background
In the early 1990s, the world faced a stark environmental warning: the ozone layer, Earth’s natural shield against harmful ultraviolet radiation, was thinning at alarming rates. The culprit? Chlorofluorocarbons (CFCs), chemicals widely used in refrigeration, air conditioning, and even inhalers